^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

MDC-CAR-BCMA001

i
Other names: MDC-CAR-BCMA001
Associations
Company:
Dresden University of Technology, German Cancer Research Center
Drug class:
BCMA-targeted CAR-T immunotherapy
Related drugs:
Associations
10ms
Enrollment open • CAR T-Cell Therapy
|
CD31 (Platelet and endothelial cell adhesion molecule 1) • SLAMF7 (SLAM Family Member 7)
|
CD38 positive
|
MDC-CAR-BCMA001
1year
Trial initiation date • CAR T-Cell Therapy
|
CD31 (Platelet and endothelial cell adhesion molecule 1) • SLAMF7 (SLAM Family Member 7)
|
CD38 positive
|
MDC-CAR-BCMA001
over1year
New P1 trial • CAR T-Cell Therapy
|
CD31 (Platelet and endothelial cell adhesion molecule 1) • SLAMF7 (SLAM Family Member 7)
|
CD38 positive
|
MDC-CAR-BCMA001